Copyright © 1992 by the European Society of Cardiology.
© 1992 The European Society of Cardiology
Heart involvement in AIDS: a prospective study during various stages of the disease
*Service of Cardiology and Echocardiography, 6th Clinica Medica, ‘La Sapienza’ University Rome, Italy
Department of Human Biopathology, Section of Pathological Anatomy, ‘La Sapienza’ University Rome, Italy
2nd Medical Pathology, ‘La Sapienza’ University Rome, Italy
Institute of Infectious Diseases, ‘La Sapienza’ University Rome, Italy
Received 1 October 1991; revised 28 April 1992; .
Correspondence Dr Stefano De Castro, Università ‘La Sapienza’, Isututo di Clinica Medica VI, Policlimco Umberto I, 00100 Roma, Italy
Abstract
The goal of our study was to evaluate the incidence of heart involvement in AIDS patients during various stages of the disease. Between January 1988 to September 1991, we conducted a prospective study in 114 anti-HIV positive patients. The patients, whose mean age ( ± SD) was 34·6 ± 5·4 years (range 20 to 54), were divided into three groups: anti-HIV positive asymptomatic (n = 31; 27%), AIDS related complex (ARC) group IV-A (n=11; 10%), and AIDS subgroups IV-C1 (n = 62; 54%) and IV-D (n=10;9%). Overall, 84 patients (74%) were i.v. drug abusers, 24 (21%) were homosexuals, and six (5%) were partners at risk. Zidovudine (AZT) was administered to 94 patients (82%). Opportunistic infections and/or secondary malignancies were detected in 72 patients (63%). Electrocardiographic changes were of little clinical relevance. Of 72 AIDS patients, 47 (65·2%) presented a cardiac involvement: 12 subjects (16·6%) were affected by a dilated cardiomyopathy, 13 (18%) by pericardial effusion, three (4·1%) by mitral valve prolapse, four (5·5%) by myocarditis, five (6·9%) by valvular bacterial endocarditis, and 10 (13·8%) by alterations of left ventricle regional contractility. During a mean follow-up period of 44 months, 29 AIDS patients (40·2%) died. Death was attributed to a cardiac event in four patients; autopsy could be performed in 24 of the 29 patients who died. Our results demonstrate that heart involvement is present in 45·6% of HIV-infected patients, but only in the end-stage of the disease (AIDS) and it is presumably due to opportunistic infections and/or secondary malignancies. The direct role of HIV in the genesis of cardiomyopathy remains uncertain and will be evaluated by further studies.
Key Words: AIDS • heart • Doppler echocardiography
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Imazio, E. Cecchi, B. Demichelis, S. Ierna, D. Demarie, A. Ghisio, F. Pomari, L. Coda, R. Belli, and R. Trinchero Indicators of Poor Prognosis of Acute Pericarditis Circulation, May 29, 2007; 115(21): 2739 - 2744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kjaer, A.-M. Lebech, J. Gerstoft, B. Hesse, and C. L. Petersen Right Ventricular Volume and Mass Determined by Cine Magnetic Resonance Imaging in HIV Patients with Possible Right Ventricular Dysfunction Angiology, May 1, 2006; 57(3): 341 - 346. [Abstract] [PDF]
|
|
|
|
 |
|
 Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur. Heart J., April 1, 2004; 25(7): 587 - 610. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Imazio, B. Demichelis, I. Parrini, M. Giuggia, E. Cecchi, G. Gaschino, D. Demarie, A. Ghisio, and R. Trinchero Day-hospital treatment of acute pericarditis: A management program for outpatient therapy J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1042 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A Chaves, M. J Mihm, B. L Schanbacher, A. Basuray, C. Liu, L. W Ayers, and J. Anthony Bauer Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues Cardiovasc Res, October 15, 2003; 60(1): 108 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Gowda, I. A. Khan, N. J. Mehta, M. R. Gowda, T. J. Sacchi, and B. C. Vasavada Cardiac Tamponade in Patients with Human Immunodeficiency Virus Disease Angiology, July 1, 2003; 54(4): 469 - 474. [Abstract] [PDF]
|
|
|
|
 |
|
 R. L. Sutliff, S. Dikalov, D. Weiss, J. Parker, S. Raidel, A. K. Racine, R. Russ, C. P. Haase, W. R. Taylor, and W. Lewis Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2363 - H2370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Panther How HIV infection and its treatment affects the cardiovascular system: what is known, what is needed Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H1 - H4. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Silva-Cardoso, B. Moura, L. Martins, A. Mota-Miranda, F. Rocha-Goncalves, and H. Lecour Pericardial Involvement in Human Immunodeficiency Virus Infection Chest, February 1, 1999; 115(2): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A M van Doorn, R. Yates, and V. T Tsang Endocarditis as the first presentation of AIDS in infancy Arch. Dis. Child., August 1, 1998; 79(2): 179 - 180. [Abstract] [Full Text]
|
|
|
|
 |
|
 P F Currie, J H Goldman, A L P Caforio, A J Jacob, M K Baig, R P Brettle, A J Haven, N A Boon, and W J McKenna Cardiac autoimmunity in HIV related heart muscle disease Heart, June 1, 1998; 79(6): 599 - 604. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Heidenreich, M. J. Eisenberg, L. L. Kee, C. A. Somelofski, H. Hollander, N. B. Schiller, and M. D. Cheitlin Pericardial Effusion in AIDS : Incidence and Survival Circulation, December 1, 1995; 92(11): 3229 - 3234. [Abstract] [Full Text]
|
|